| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥39.3B | ¥42.3B | -7.3% |
| Operating Income | ¥1.4B | ¥0.1B | -88.9% |
| Ordinary Income | ¥1.5B | - | +453.0% |
| Net Income | ¥2.2B | ¥0.3B | +641.0% |
| ROE | 13.0% | 2.0% | - |
FY2025 annual results: Revenue 39.3B yen (YoY -7.3%), Operating Income 1.4B yen (YoY -88.9%), Ordinary Income 1.5B yen (YoY +453.0%), Net Income 2.2B yen (YoY +641.0%). The company experienced revenue contraction while operating profit deteriorated significantly. However, net income turned positive primarily due to extraordinary income of 0.9B yen from securities sales. Basic EPS improved dramatically to 25.16 yen from -3.59 yen prior year. Operating cash flow of 2.8B yen (YoY +37.5%) demonstrates healthy cash generation capability. The significant gap between operating income (1.4B yen) and net income (2.2B yen) reflects the substantial contribution of non-recurring gains, raising concerns about earnings sustainability.
Revenue declined 7.3% YoY to 39.3B yen, driven by contractions in both reporting segments. The Acupuncture Moxibustion and Judo Therapy Clinic Support segment (A-COMS) recorded revenue of 23.7B yen (down from 24.5B yen prior year, -3.7%), while Toy Sales segment revenue fell to 15.7B yen (down from 17.9B yen prior year, -12.1%). The Toy Sales segment faced more severe headwinds with double-digit revenue contraction. Gross profit margin remained relatively stable at 34.3% (gross profit 13.5B yen), indicating maintained pricing power despite top-line pressure. SG&A expenses of 12.1B yen represented 30.7% of revenue, resulting in compressed operating leverage.
Operating income contracted sharply by 88.9% to 1.4B yen from minimal prior year profit of 0.1B yen. This deterioration stems from the combination of revenue decline and relatively fixed SG&A expense base. The operating margin compressed to 3.6% from near breakeven in the prior period. Non-operating items contributed modestly, with partnership gains of 0.1B yen offsetting interest expenses of 0.1B yen, resulting in ordinary income of 1.5B yen.
The dramatic improvement in net income to 2.2B yen (from 0.3B yen prior year) was driven by extraordinary income of 0.9B yen, primarily consisting of gains on sale of investment securities. This non-recurring factor accounted for approximately 40% of pretax profit of 2.4B yen. Additionally, the company recorded impairment losses of 0.3B yen as extraordinary losses. The effective tax rate was negative at -8.3% (tax benefit of 0.2B yen), contributing to the net income boost. This represents a classic "revenue down, profit up" pattern, where bottom-line improvement is achieved through non-operating and extraordinary items rather than operational excellence.
The Acupuncture Moxibustion and Judo Therapy Clinic Support segment (A-COMS) generated revenue of 23.7B yen with operating income of 1.6B yen, achieving a 6.9% operating margin. This segment represents 60.2% of total revenue and serves as the core business, demonstrating profitability despite the challenging operating environment. Segment profit increased substantially from 0.04B yen prior year, reflecting improved operational efficiency within this business line.
The Toy Sales segment recorded revenue of 15.7B yen with an operating loss of 0.3B yen, resulting in a negative margin of -1.6%. This segment comprises 39.8% of total revenue but continues to struggle with profitability. The operating loss narrowed from -0.36B yen prior year, showing marginal improvement in loss reduction. The profitability disparity between segments is material, with the A-COMS segment's positive 6.9% margin contrasting sharply with Toy Sales' negative margin. The company's overall profitability depends heavily on A-COMS segment performance, while Toy Sales remains a drag requiring structural improvement or strategic reassessment.
[Profitability] ROE of 13.0% reflects leveraged returns on a modest equity base of 16.9B yen, though this metric is inflated by extraordinary gains. Operating margin of 3.6% indicates weak operational profitability requiring improvement. Gross profit margin of 34.3% demonstrates reasonable cost structure at the product level. Net profit margin of 5.6% benefited significantly from non-recurring securities gains. [Cash Quality] Cash and deposits of 11.3B yen provide substantial liquidity, representing 2.3x coverage of short-term debt obligations. Operating cash flow of 2.8B yen exceeded net income, demonstrating solid cash conversion. Free cash flow of 3.1B yen indicates strong cash generation after capex of 0.4B yen. [Investment Efficiency] Total asset turnover of 0.95x shows moderate asset utilization efficiency. Inventory turnover of 85 days indicates room for working capital optimization. Capex to depreciation ratio of 0.38x suggests potential underinvestment in long-term growth. [Financial Health] Equity ratio of 41.1% reflects a balanced capital structure. Current ratio of 199.2% and quick ratio of 156.4% demonstrate robust short-term liquidity. Debt-to-equity ratio of 0.49x (total interest-bearing debt of 8.3B yen versus equity of 16.9B yen) indicates conservative leverage. Net defined benefit liability of 0.8B yen represents a manageable pension obligation. Retained earnings of -0.5B yen reflect accumulated historical losses, though the current period added 2.2B yen to this account.
Operating cash flow of 2.8B yen represents 1.27x of net income of 2.2B yen, confirming cash-backed earnings quality. The operating cash flow subtotal before working capital changes was 3.1B yen, with working capital movements showing inventory decrease of 0.5B yen contributing positively, partially offset by receivables increase of 0.4B yen and payables decrease of 0.2B yen. Income taxes paid of 0.2B yen and interest paid of 0.1B yen were modest outflows. Investing cash flow of 0.4B yen included capex of 0.4B yen alongside proceeds from asset disposals. The resulting free cash flow of 3.1B yen demonstrates strong cash generation capability. Financing cash flow of -2.3B yen reflected debt repayment and other financing activities, contributing to the overall prudent capital management approach. Depreciation and amortization of 1.1B yen exceeded capex spending, indicating potential underinvestment in fixed asset renewal. Cash and deposits increased to 11.3B yen, providing a comfortable liquidity cushion representing 28.8% of total assets.
Ordinary income of 1.5B yen versus operating income of 1.4B yen shows minimal non-operating net contribution of approximately 0.1B yen. Non-operating income of 0.2B yen consisted primarily of partnership gains of 0.1B yen and minor interest income, offset by non-operating expenses of 0.2B yen including interest expense of 0.1B yen. The relatively neutral non-operating result indicates limited impact from financial activities on core profitability. However, the significant gap emerges between ordinary income (1.5B yen) and net income (2.2B yen), driven by extraordinary income of 0.9B yen from securities sales, representing approximately 2.3% of revenue. This one-time gain substantially boosted reported earnings, raising sustainability concerns. Impairment losses of 0.3B yen were recorded as extraordinary losses, partially offsetting the gains. Operating cash flow of 2.8B yen exceeding net income of 2.2B yen indicates fundamentally healthy earnings quality from operating activities, though the earnings composition reveals significant dependence on non-recurring items for bottom-line performance.
Full-year guidance indicates revenue of 35.0B yen (YoY -10.9%), operating income of 0.8B yen (YoY -43.2%), and ordinary income of 0.7B yen (YoY -52.9%). Actual results showed revenue of 39.3B yen, representing 112.2% achievement versus the revised forecast, suggesting guidance was conservative or revised downward during the period. Operating income of 1.4B yen achieved 175.0% of the 0.8B yen forecast, indicating better-than-expected cost control or one-time factors. Ordinary income of 1.5B yen represents 214.3% of the 0.7B yen guidance, significantly exceeding expectations due primarily to extraordinary securities gains not reflected in the original forecast. The forecast assumes no dividend (0.00 yen) and projects EPS of 5.84 yen, substantially below the actual EPS of 25.16 yen achieved in the current period. This gap underscores the non-recurring nature of current period earnings drivers. The conservative guidance for the next period reflects management's expectation of continued revenue headwinds and normalization of profit levels absent extraordinary gains.
No dividend was paid for the current fiscal year, maintaining the zero dividend policy from prior periods. With net income of 2.2B yen, the payout ratio is 0%, indicating full retention of earnings for balance sheet restoration and potential reinvestment. The forecast for the next fiscal year also indicates a planned dividend of 0.00 yen, suggesting dividend resumption is not imminent. No share buyback activity was disclosed during the period. The total return ratio to shareholders therefore remains at 0%. The company's negative retained earnings of -0.5B yen, despite improvement from -3.1B yen prior year, likely constrains dividend capacity from a legal and financial prudence perspective. Given the extraordinary nature of current period earnings and conservative future guidance, the suspension of shareholder returns appears appropriate to prioritize financial stability and business reinvestment.
Revenue concentration risk exists with heavy dependence on the A-COMS segment (60% of revenue) for profitability, while the Toy Sales segment (40% of revenue) operates at a loss. Any deterioration in the A-COMS business would significantly impact overall profitability. Current period A-COMS revenue declined 3.7% YoY, indicating the core business faces headwinds requiring close monitoring.
Earnings quality risk stems from significant reliance on non-recurring gains to achieve positive net income. Extraordinary income of 0.9B yen from securities sales represented 40% of pretax profit. Operating income of 1.4B yen alone translates to only 3.6% operating margin, insufficient to drive sustainable profitability absent additional asset monetization or operational improvement. The forecast projects operating income declining to 0.8B yen, acknowledging this challenge.
Working capital efficiency risk is evident from inventory turnover of 85 days and capex-to-depreciation ratio of 0.38x. Underinvestment in fixed assets may compromise long-term competitive positioning, while elevated inventory levels tie up 6.0B yen in working capital (15% of total assets). Inventory increased from prior period levels, potentially indicating demand weakening or procurement inefficiencies that could pressure future margins if markdowns are required.
[Industry Position] (Reference - Proprietary Analysis)
The company's operating margin of 3.6% is positioned at the lower end of profitability metrics for diversified service and retail businesses. ROE of 13.0%, while appearing favorable, is significantly influenced by extraordinary gains and financial leverage rather than operational excellence. The equity ratio of 41.1% indicates moderate financial stability, though accumulated deficit in retained earnings reflects historical challenges. Revenue growth of -7.3% YoY underperforms typical industry growth expectations in both healthcare support services and retail sectors, which generally target low single-digit to mid-single-digit growth rates. The company's cash conversion remains a relative strength, with operating cash flow exceeding net income, though this advantage is offset by weak operating margins. The bifurcated segment performance, with A-COMS achieving positive margins while Toy Sales operates at a loss, suggests structural challenges in portfolio management. Industry peers in clinic support services typically achieve operating margins in the 5-10% range, positioning this company below median. The absence of dividend payments contrasts with mature industry participants that typically distribute returns, reflecting the company's recovery phase status.
※ Industry: Healthcare Support Services and Specialty Retail, Comparison: Fiscal year 2025 results, Source: Proprietary analysis
Earnings structure reveals heavy dependence on non-recurring factors, with extraordinary gains from securities sales (0.9B yen) accounting for a substantial portion of net income (2.2B yen). The sustainable operating profit base of 1.4B yen translates to only 3.6% operating margin, indicating operational profitability requires significant improvement. Management's conservative guidance for the next period (operating income of 0.8B yen, -43% YoY) acknowledges the normalization of earnings absent extraordinary items. This trend suggests near-term earnings volatility and limited visibility into sustainable profit generation.
Cash generation remains a fundamental strength, with operating cash flow of 2.8B yen exceeding net income and free cash flow of 3.1B yen providing financial flexibility. The company maintains substantial liquidity with 11.3B yen in cash and deposits, representing 28.8% of total assets. However, the low capex-to-depreciation ratio of 0.38x raises concerns about potential underinvestment in long-term growth infrastructure. The tension between strong current cash generation and modest reinvestment levels may constrain future competitiveness unless addressed through strategic capital allocation decisions.
Segment performance divergence highlights portfolio optimization needs, with the A-COMS segment (60% of revenue) driving all profitability at 6.9% operating margin while Toy Sales (40% of revenue) operates at -1.6% margin. The structural challenges in Toy Sales, evidenced by consecutive periods of losses and 12% revenue decline, warrant strategic review. The company's ability to either turn around or exit the underperforming segment will be critical to achieving sustainable consolidated profitability and margin improvement beyond the current low single-digit operating margin level.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.